Stock VSTM VERASTEM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Verastem, Inc.

Equities

VSTM

US92337C2035

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-23 pm EDT 		Pre-market 09:23:38 am
12.18 USD +2.53% Intraday chart for Verastem, Inc. 4.725 -61.21%
03:01pm Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer MT
May. 23 Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
VERASTEM, INC.
Bio Therapeutic Drugs
+2.53%+0.41%+49.63%+121.52%-26.45% 308M
Bullish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. VSTM Stock
  4. Charts Verastem, Inc.
  5. Comparison Chart